Last updated on June 2018

A Lactation Study in Women Who Are Breastfeeding or Pumping and Are Receiving Linaclotide Therapeutically


Brief description of study

The purpose of this study is to determine the amount of linaclotide and its active metabolite (MM-419447) excreted in breast milk after multiple, once daily doses of linaclotide (145 g or 290 g) in lactating women receiving the drug therapeutically.

Clinical Study Identifier: NCT02220348

Contact Investigators or Research Sites near you

Start Over

Danielle McGeeney

Forest Investigative Site 002
Philadelphia, PA United States
  Connect »